跳至主要内容
临床试验/NCT04807101
NCT04807101已完成早期 1 期

A Randomized Study of Midazolam and Fentanyl Versus Midazolam Alone for Sedation in Gastrointestinal Endoscopy

Greg S Cohen MD LLC1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年4月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
300
试验地点
1
主要终点
Pain Felt During the Procedure

研究概览

简要总结

This is a noninferiority study designed to examine whether conscious sedation with midazolam alone results in efficacy and safety that is not inferior to the combination of midazolam and fentanyl. English-speaking patients ≥18 years old and ≤75 years old presenting for GI endoscopy planned with conscious sedation using midazolam and fentanyl, will be randomized 1:1 to single agent sedation with midazolam or combination sedation with midazolam and fentanyl. Participants will be blinded to the choice of sedation. Sedation quality and adverse events will be measured with a validated patient-centered measure of procedural sedation quality, the PROcedural Sedation Assessment Survey (PROSAS) [Leffler, et al. Gastrointest Endosc. 2015;81(1):194-203]. Endoscopic quality measures in the 2 study groups will be collected by retrospective chart review, as an additional metric to ensure the quality of the procedure is not compromised by the choice of sedation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English-speaking patients
  • Patients ≥18 years old and ≤75 years old
  • Outpatients presenting for EGD and/or colonoscopy planned with conscious sedation using midazolam and fentanyl
  • Patients presenting for endoscopic procedures with no GI fellow or trainee involvement in the procedure

排除标准

  • Patients with an allergy or prior adverse event to either fentanyl or midazolam
  • Patients who have previously not tolerated endoscopy with conscious sedation and require monitored anesthesia care (MAC)
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Vulnerable populations, including cognitively impaired adults and adults who are otherwise unable to consent

研究组 & 干预措施

midazolam alone

Experimental

Patients in this arm will receive conscious sedation with medazepam alone

干预措施: midazolam alone (Drug)

结局指标

主要结局

Pain Felt During the Procedure

时间窗: 1 day

Level of discomfort during the procedure as assessed by the previously validated PROcedural Sedation Assessment Survey (PROSAS) questionnaire \[Leffler, et al. Gastrointest Endosc. 2015;81(1):194-203\]. The patient will answer the question "How much discomfort did you experience during the procedure?" A visual analog scale will be used ranging from 0 to 10 with higher numbers indicating more pain.

Adequacy of Sedation

时间窗: 1 day

Adequacy of sedation as assessed by the previously validated PROcedural Sedation Assessment Survey (PROSAS) questionnaire \[Leffler, et al. Gastrointest Endosc. 2015;81(1):194-203\]. The patient will answer the question "If having this procedure again in the future, how much sedation would you prefer to have?" A visual analog scale will be used ranging from -5 to 5, with lower numbers indicating a preference for less sedation in the future and higher numbers indicating a preference for more sedation in the future.

次要结局

  • Patient Reported Nausea(1 day)
  • Adverse Events(1 day)
  • Cecal Intubation Rate(through study completion, an average of 1 year)
  • Cecal Intubation Time(through study completion, an average of 1 year)
  • Adenoma Detection Rate(through study completion, an average of 1 year)
  • Colonoscopy Withdrawal Time(through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Greg Cohen

Clinical Associate Professor of Medicine

Greg S Cohen MD LLC

研究点 (1)

Loading locations...

相似试验

Sedation Regimens in GI Endoscopy | 临床试验